DENTSPLY SIRONA Inc (NASDAQ:XRAY) was the recipient of a significant growth in short interest in the month of March. As of March 13th, there was short interest totalling 6,120,000 shares, a growth of 153.9% from the February 27th total of 2,410,000 shares. Currently, 2.8% of the company’s shares are short sold. Based on an average daily trading volume, of 2,752,800 shares, the days-to-cover ratio is presently 2.2 days.
DENTSPLY SIRONA stock opened at $39.40 on Friday. The stock’s 50-day moving average is $47.99 and its 200-day moving average is $53.79. The company has a market cap of $7.49 billion, a price-to-earnings ratio of 33.68, a price-to-earnings-growth ratio of 1.22 and a beta of 0.96. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.01 and a quick ratio of 1.44. DENTSPLY SIRONA has a 12 month low of $31.58 and a 12 month high of $60.87.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Monday, March 2nd. The medical instruments supplier reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.02). The firm had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.09 billion. DENTSPLY SIRONA had a return on equity of 10.76% and a net margin of 6.52%. The business’s revenue for the quarter was up 4.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.58 earnings per share. Research analysts anticipate that DENTSPLY SIRONA will post 2.58 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 10th. Stockholders of record on Friday, March 27th will be issued a $0.10 dividend. The ex-dividend date of this dividend is Thursday, March 26th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.02%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 16.33%.
Several equities analysts recently weighed in on XRAY shares. Stifel Nicolaus reduced their target price on DENTSPLY SIRONA from $66.00 to $56.00 and set a “buy” rating on the stock in a research report on Friday, March 13th. JPMorgan Chase & Co. reduced their target price on DENTSPLY SIRONA from $65.00 to $45.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 17th. Barclays reiterated a “hold” rating and set a $64.00 target price on shares of DENTSPLY SIRONA in a research report on Sunday, January 19th. Barrington Research reduced their target price on DENTSPLY SIRONA from $63.00 to $60.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 3rd. Finally, BidaskClub downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Wednesday, March 4th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $55.88.
Several institutional investors have recently added to or reduced their stakes in the company. Verus Capital Partners LLC acquired a new stake in shares of DENTSPLY SIRONA in the fourth quarter valued at about $35,000. Private Ocean LLC acquired a new stake in shares of DENTSPLY SIRONA in the fourth quarter valued at about $47,000. Rational Advisors LLC grew its stake in shares of DENTSPLY SIRONA by 27.3% in the fourth quarter. Rational Advisors LLC now owns 859 shares of the medical instruments supplier’s stock valued at $49,000 after buying an additional 184 shares in the last quarter. Fieldpoint Private Securities LLC grew its stake in shares of DENTSPLY SIRONA by 54.9% in the fourth quarter. Fieldpoint Private Securities LLC now owns 987 shares of the medical instruments supplier’s stock valued at $55,000 after buying an additional 350 shares in the last quarter. Finally, Orion Portfolio Solutions LLC acquired a new stake in shares of DENTSPLY SIRONA in the fourth quarter valued at about $61,000. Institutional investors own 95.61% of the company’s stock.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Further Reading: 52 Week Highs
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.